Variable Yoga (n=7) Resistance (n=7) p-value Chicago (n=9) LF (n=5) p-value
Age (yrs) 67.9 (SD 10.9) 66.7 (SD 9.3) 0.83 65.4 (SD 10.0) 70.6 (SD 9.6) 0.37
Gender (M/F) 5/2 6/1 n/a 6/3 5/0 n/a
Race (White/Non-white) 6/1 5/2 n/a 7/2 4/1 n/a
Baseline H&Y 2.3 (SD 0.4) 2.4 (SD 0.5) 0.61 2.3 (SD 0.5) 2.4 (SD 0.5) 0.83
Baseline LED 328 (SD 255) 486 (SD 478) 0.46 369.4 (SD 196.4) 476 (SD 614.0) 0.72
Baseline MOCA 26.8 (SD 1.77) 26.8 (SD 1.77) 1 26.5 (SD 1.6) 27.4 (SD 1.9) 0.43
Baseline BDI 4.57 (SD 4.54) 7.57 (SD 3.35) 0.18 6.2 (SD 4.6) 5.8 (SD 3.4) 0.85
Baseline TUG (sec) 9.86 (SD 2.11) 10.04 (SD 1.17) 0.85 9.7 (SD 1.7) 10.4 (SD 1.5) 0.47
Baseline BBS 52.28 (SD 2.92) 52.71 (SD 2.69) 0.78 53.2 (SD 2.28) 51.2 (SD 3.2) 0.25
Baseline UPDRS III 25.85 (SD 6.91) 22.57 (SD 7.23) 0.4 24.1 (SD 6.5) 24.4 (SD 8.7) 0.95
Baseline UPDRS Total 36.43 (SD 9.94) 35.49 (SD 8.69) 0.84 35.3 (SD 8.9) 37.0 (SD 10.0) 0.77
Baseline PDQ-39 20.00 (SD 22.55) 21.14 (SD 9.47) 0.9 23.1 (SD 18.1) 16 (SD 14.1) 0.43
Baseline FES-1 23.14 (SD 6.06) 21.85 (SD 4.33) 0.65 22.0 (SD 5.8) 23.4 (SD 4.0) 0.61
Baseline FOG 2.71 (SD 2.62) 3.14 (SD 3.43) 0.79 3.0 (SD 2.8) 2.8 (SD 3.5) 0.91
Baseline FF 1.28 (SD 1.38) 0.86 (SD 0.89) 0.51 1.2 (SD 1.3) 0.8 (SD 0.8) 0.47
There are no significant differences in baseline clinical characteristics between yoga and resistance groups or between Chicago and Lake Forest groups. The majority of the participants were white males.
H&Y=Hoehn & Yahr; LED=Levodopa Equivalent Dose, calculated based on the formula reported by Tomlinson et al [36]; MOCA=Montreal Cognitive Assessment; BDI=Beck Depression Inventory; TUG=Timed-Up-And-Go; BBS=Berg Balance Scale; UPDRS=Unified Parkinson Disease Rating Scale; PDQ-39=Parkinson Disease Questionnaire; FES-1=Falls Efficacy Scale; FOG=Giladi Freezing of Gait Scale; FF=Fall Frequency Scale
Table 1: Baseline demographics.